Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): Introduction to the collaborative trial

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 702, Issue 2, 2010, Pages 135-138

  Kirkland, David ^a  

^a Department of Genetic and Molecular Toxicology   (United Kingdom)

Author keywords

Cytotoxicity; In vitro micronucleus test

Indexed keywords

2 AMINOANTHRACENE; BENZO[A]PYRENE; CADMIUM CHLORIDE; COLCHICINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOCHALASIN B; CYTOTOXIC AGENT; DIETHYLSTILBESTROL; ETOPOSIDE; FLUOROURACIL; MITOMYCIN C; VINBLASTINE;

ANIMAL CELL; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; EDITORIAL; GENOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL COUNT; CELL LINE; CELL PROLIFERATION; CYTOCHALASIN B; CYTOSTATIC AGENTS; CYTOTOXINS; EVALUATION STUDIES AS TOPIC; HUMANS; MICRONUCLEUS TESTS; MUTAGENS;

EID: 77958081677     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.02.005     Document Type: Editorial

References (27)

1. OECD Guideline for Testing of Chemicals. No. 487: In Vitro Mammalian Cell Micronucleus Test (MNvit). Draft. Available: []. http://www.oecd.org/document/55/0,3343,en_2649_34377_2349687_1_1_1_1,00.html.
2. Greenwood S.K., Hill R.B., Sun J.T., Armstrong M.J., Johnson T.E., Gara J.P., Galloway S.M. Population doubling: a simple and more accurate estimation of cell growth suppression in the in vitro assay for chromosomal aberrations that reduces irrelevant positive results. Environ. Mol. Mutagen. 2004, 43:36-44.
3. Galloway S.M. Cytotoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ. Mol. Mutagen. 2000, 35:191-201.
4. Kirkland D., Pfuhler S., Tweats D., Aardema M., Corvi R., Darroudi F., Elhajouji A., Glatt H., Hastwell P., Hayashi M., Kasper P., Kirchner S., Lynch A., Marzin D., Maurici D., Meunier J.-R., Müller L., Nohynek G., Parry J., Parry E., Thybaud V., Tice R., van Benthem J., vanParys P., White P. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM workshop. Mutat. Res. 2007, 628:31-55.
5. Matthews E.J., Kruhlak N.L., Cimino M.C., Benz R.D., Contrera J.F. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data. I. Identification of carcinogens using surrogate endpoints. Regul. Toxicol. Pharmacol. 2006, 44:83-96.
6. Kirkland D., Aardema M., Henderson L., Müller L. Evaluation of the ability of a battery of 3 in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res. 2005, 584:1-256.
7. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M., Lorge E., Norppa H., Surallés J., von der Hude W., Wakata A. Report from the in vitro micronucleus assay working group. Environ. Mol. Mutagen. 2000, 35:167-172.
8. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M., Kirchner S., Lorge E., Morita T., Norppa H., Surallés J., Vanhauwaert A., Wakata A. Report from the in vitro micronucleus assay working group. Mutat. Res. 2003, 540:153-163.
9. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M., Kirchner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A., Wakata A. Corrigendum to "Report from the in vitro micronucleus assay working group" Mutat. Res. 2004, 564:97-100.
10. Lorge E., Hayashi M., Albertini S., Kirkland D. Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. I. Theoretical aspects. Mutat. Res. 2008, 655:1-3.
11. Fellows M.D., O'Donovan M.R., Lorge E., Kirkland D. Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. II. Practical aspects with toxic agents. Mutat. Res. 2008, 655:4-21.
12. Matsushima T., Hayashi M., Matsuoka A., Ishidate M., Miura K.F., Shimizu H., Suzuki Y., Morimoto K., Ogura H., Mure K., Koshi K., Sofuni T. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis 1999, 14:569-580.
13. Von der Hude W., Kalweit S., Engelhardt G., McKiernan S., Kasper P., Slacik-Erben R., Miltenburger H.G., Honarvar N., Fahrig R., Görlitz B., Albertini S., Kirchner S., Utesch D., Pötter-Locher F., Stopper H., Madle S. In vitro micronucleus assay with Chinese hamster V79 cells-results of a collaborative study with in situ exposure to 26 chemical substances. Mutat. Res. 2000, 468:137-163.
14. Lorge E., Thybaud V., Aardema M.J., Oliver J., Wakata A., Lorenzon G., Marzin D. SFTG international collaborative study on in vitro micronucleus test. I. General conditions and overall conclusions of the study. Mutat. Res. 2006, 607:13-36.
15. Tsutsui T., Tamura Y., Yagi E., Hasegawa K., Tanaka Y., Uehama A., Someya T., Hamaguchi F., Yamamoto H., Barrett J.C. Cell-transforming activity and genotoxicity of phenolphthalein in cultured Syrian hamster embryo cells. Int. J. Cancer 1997, 73:697-701.
16. Armstrong M.J., Gara J., Gealy R., Greenwood S.K., Hilliard C.A., Laws G.M., Galloway S.M. Induction of chromosome aberrations in vitro by phenolphthalein: mechanistic studies. Mutat. Res. 2000, 457:15-30.
17. NTP, NTP website at http://ntp-server.niehs.nih.gov/.
18. Gibson D.P., Brauninger R., Shaffi H.S., Kerckaert G.A., LeBoeuf R.A., Isfort R.J., Aardema M.J. Induction of micronuclei in Syrian hamster embryo cells: comparison to results in the SHE cell transformation assay for National Toxicology Program test chemicals. Mutat. Res. 1997, 392:61-70.
19. Bishop M.E., Aidoo A., Doman O.E., Morris S.M., Casciano D.A. Phenolphthalein induces micronuclei in transgenic human lymphoblastoid cells. Environ. Mol. Mutagen. 1998, 32:286-288.
20. Witt K.L., Gulati D.K., Kaur P., Shelby M.D. Phenolphthalein: induction of micronucleated erythrocytes in mice. Mutat. Res. 1995, 341:151-160.
21. Lafi A., Parry J.M. A study of the induction of aneuploidy and chromosome aberrations after diazepam, medazepam, midazolam and bromazepam treatment. Mutagenesis 1988, 3:23-27.
22. Izzo M., Antoccia A., Degrassi F., Tanzarella C. Immunofluorescence analysis of diazepam-induced mitotic apparatus anomalies and chromosome loss in Chinese hamster cells. Mutagenesis 1998, 13:445-451.
23. Miller B., Pötter-Locher F., Seelbach A., Stopper H., Utesch D., Madle S. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Mutat. Res. 1998, 410:81-116.
24. Staiger G.R. Studies on the chromosomes of human lymphocytes treated with diazepam in vitro. Mutat. Res. 1970, 10:635-644.
25. Hitotsumachi S., Kimura Y., Nakajima Y., Hayashi M., Ishidate M. Micronucleus test on quinacrine dihydrochloride in mice: a comparison of dosage regimens. Mutat. Res. 1990, 234:141-145.
26. Clarke J.J., Sokal D.C., Cancel A.M., Campen D.B., Gudi R., Wagner V.O., San R.H.C., Jacobson-Kram D. Re-evaluation of the mutagenic potential of quinacrine dihydrochloride dehydrate. Mutat. Res. 2001, 494:41-53.
27. Mientières S., Biola A., Pallardy M., Marzin D., Using CTLL-2 CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test. Environ. Mol. Mutagen. 2003, 41:14-27.